In 2019, Neuralink allegedly mishandled devices removed from the brains of primates that may have been contaminated with viruses such as herpes B and bacteria like Staphylococcus and Klebsiella.
The Department of Transportation was first alerted to the alleged violations in a letter from the Physicians Committee for Responsible Medicine, a group that opposes animal testing in medicine.
The PCRM obtained records from the University of California Davis, a Neuralink research partner, that showed researchers raised concerns about mishandled materials.
“Since the hardware components of the explanted neural device are not sealed and it was not disinfected prior to leaving the Primate Center, this presents a hazard for anyone potentially coming in contact with the device,” the UC Davis staffer said in the email. “Simply labeling it ‘hazardous’ doesn’t account for the risk of potentially contracting Herpes B.”
Neuralink did not respond to CNBC’s request for comment.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
